Guideline for postmarketing Chinese medicine pharmacoeconomic evaluation

• DOI: 10.1007/s11655-014-1749-y
• Publication Date: 2014-03-26T17:41:35Z
• Authors: Xin Wang; Zhi-fei Wang; Yan-ming Xie; Wen Zhang; Xing Liao; Yan-peng Chang
• Keywords: Guideline; Postmarketing surveillance

Pharmacoeconomics is an important part of the postmarketing Chinese medicine (CM) evaluation, and postmarketing pharmacoeconomic evaluation can reveal the clinical and market value of CM. The purpose of establishing the guideline for pharmacoeconomic evaluation is to make the evaluation process and results regarding Chinese patent medicines both scientific and fair. Every country's guidelines for pharmacoeconomic evaluation act as reference guidelines, we have already drawn up the guideline that takes into account the special characteristics of CM; and these are in preparation for the postmarketing CM pharmacoeconomic evaluation.